Clinical Trial

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the factors that contribute to chronic graft-versus-host disease, which is a complication that can occur after allogeneic hematopoietic cell transplantation.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Withdrawn 2026-07-14
critical Reason stopped changed: — → 05/28/26-The accrual status of this study at City of Hope has been changed at the request of the BDRC due to pending study activation No subjects have been accrued to this study. 2026-07-14
notable Enrollment reduced: 75 -> 0 participants 2026-07-14
Trial Details
NCT Number NCT07235501
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Enrollment 75 participants
Start Date 2026-10-01
Primary Completion 2030-01-17 (estimated)
Study Completion 2030-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-22